CX3CR1 and myeloid sarcoma: We previously showed that CX3CR1 is expressed on mature NK cells [86] and that MS patients have a reduced proportion of circulating CX3CR1+ NK cells, although increased frequency of peripheral CX3CR1+ NK cells correlates with an enhanced MS activity [40].